Circadian Clock Dysfunction Exacerbate Autistic‐Like Behaviour and Wnt/β‐Catenin Signalling Dysregulation in ASD Mice and Treatment of Melatonin
Journal of Cellular and Molecular Medicine · 2026
DOI: 10.1111/jcmm.70991 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2026. Verfasst von Yuxing Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Hunan University of Chinese Medicine, Changsha, Hunan Province, China. Hauptthemen laut MEDLINE: Melatonin, Wnt Signaling Pathway, Circadian Clocks, Autism Spectrum Disorder. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Grants Postdoctoral Researchers Program of China, Natural Science Foundation of Hunan Province, National Natural Science Foundation Pre-research Project of Hunan University of Chinese Medicine.
Abstract (Originalsprache)
Between 50% and 80% of children diagnosed with Autism Spectrum Disorder (ASD) are estimated to experience sleep disturbances, highlighting the importance of exploring the role of the circadian clock in ASD development. Previous studies have identified a potential link between Bmal1 deficiency and ASD in mouse models. In this study, we first characterise the expression patterns of circadian proteins. Subsequent behavioural tests and western blot analyses revealed that mice exposed to valproic acid (VPA) displayed autistic‐like behaviours, along with altered circadian protein expression and disruption in Wnt signalling protein levels. Further studies showed that Bmal1 knockout exacerbates these behavioural changes and further impaired Wnt signalling and downstream protein expression in VPA‐exposed mice. Notably, treatment with the circadian biomarker melatonin reversed Wnt downregulation and improved the behaviour deficit in VPA‐exposed mice. The therapeutic effect of melatonin appears to be mediated by its regulation of the Wnt/β‐catenin signalling pathway, which is linked to Bmal1‐mediated circadian dysfunction. Together, our findings provide experimental evidence supporting the role of circadian dysregulation in ASD pathogenesis, highlight the therapeutic potential of melatonin in VPA‐exposed mice, and suggest that Bmal1 may act as a co‐activator in the Wnt‐β‐catenin signalling pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hunan University of Chinese Medicine, Changsha, Hunan Province, China.
- Key Laboratory of Hunan Province for Integrated Traditional Chinese and Western Medicine on Prevention and Treatment of Cardio-Cerebral Diseases, Changsha, Hunan Province, China.
ORCID-Profile: Yuxing Zhang, Xiang Feng
Förderung
- National Grants Postdoctoral Researchers Program of China
- Natural Science Foundation of Hunan Province
- National Natural Science Foundation Pre-research Project of Hunan University of Chinese Medicine
- Hunan University of Chinese Medicine Undergraduate Research Innovation Foundation
- Outstanding Youth Project of Hunan Provincial Department of Education
- National Natural Science Foundation of China
Zitieren
APA
Zhang, Y., Chen, Y., Li, W., Tang, L., Wang, G., Li, J., & Feng, X. (2026). Circadian Clock Dysfunction Exacerbate Autistic‐Like Behaviour and Wnt/β‐Catenin Signalling Dysregulation in ASD Mice and Treatment of Melatonin. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70991
Vancouver
Zhang Y, Chen Y, Li W, Tang L, Wang G, Li J, et al. Circadian Clock Dysfunction Exacerbate Autistic‐Like Behaviour and Wnt/β‐Catenin Signalling Dysregulation in ASD Mice and Treatment of Melatonin. Journal of Cellular and Molecular Medicine. 2026. doi:10.1111/jcmm.70991
BibTeX
@article{Zhang2026,
author = {Zhang, Yuxing and Chen, Yinan and Li, Wu and Tang, Liya and Wang, Guangyu and Li, Jiangshan and Feng, Xiang},
title = {Circadian Clock Dysfunction Exacerbate Autistic‐Like Behaviour and Wnt/β‐Catenin Signalling Dysregulation in ASD Mice and Treatment of Melatonin},
journal = {Journal of Cellular and Molecular Medicine},
year = {2026},
doi = {10.1111/jcmm.70991}
}
EUVIMED